Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000801492 | SCV000941269 | pathogenic | Insulin-dependent diabetes mellitus secretory diarrhea syndrome | 2022-09-20 | criteria provided, single submitter | clinical testing | This missense change has been observed in individuals with IPEX syndrome (PMID: 12161590, 18951619, 25326164, 26661331, 31990476). ClinVar contains an entry for this variant (Variation ID: 647073). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FOXP3 protein function. Experimental studies have shown that this missense change affects FOXP3 function (PMID: 16920951, 21036387). For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 347 of the FOXP3 protein (p.Arg347His). |
Mayo Clinic Laboratories, |
RCV001509120 | SCV001715659 | pathogenic | not provided | 2020-03-13 | criteria provided, single submitter | clinical testing | PS2, PS3, PS4, PM1, PM2, PP3, PP4 |
Clinical Genomics, |
RCV000801492 | SCV002605316 | likely risk allele | Insulin-dependent diabetes mellitus secretory diarrhea syndrome | criteria provided, single submitter | research | Potent mutations in FOXP3 gene are associated with a rare X linked condition called IPEX. It presents with immune dysregulation, secretory diarrhea, polyendocrinopathy which includes diabtes type 1, thyroiditis, growth hormone deficiency and hypoadrenalism. It is associated with pancreatic beta cell destruction.However no sufficient evidence is found to ascertain the role of this particular variant rs1557115786, yet. | |
Ce |
RCV001509120 | SCV003917788 | pathogenic | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | FOXP3: PM1, PM2, PS3:Moderate, PS4:Moderate, PP3, PP4 |